An Open-Label, Phase I Study to Assess the Excretion of Radioactivity, Metabolic Profiles and Pharmacokinetics Following a Single Oral Dose of [14C]AZD5672 in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Apr 2009
At a glance
- Drugs AZD 5672 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 18 Apr 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 18 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2008 New trial record.